Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.
about
The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrumAmyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies.Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic patternRole of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendationsPredictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprineClinical presentation and evaluation of dermatomyositis.Significance of myositis autoantibody in patients with idiopathic interstitial lung diseaseIncidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-AnalysisClinical characteristics of patients with anti-Jo-1 antibodies: a single center experience.Myositis-related interstitial lung disease and antisynthetase syndromeAcute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase SyndromeCharacterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung diseaseInflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study.Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009.Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.Treatment of interstitial lung diseases associated with connective tissue diseases.Clinical heterogeneity and outcomes of antisynthetase syndrome.Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools.Multiple values of (18)F-FDG PET/CT in idiopathic inflammatory myopathy.The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.Initial limited three-level thin-section computed tomography scorings predict the prognosis of acute/subacute interstitial pneumonia in patients with dermatomyositis.Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.Polymyositis and dermatomyositis: Disease spectrum and classification.Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis.Developing better biomarkers for connective tissue disease-associated interstitial lung disease: citrullinated hsp90 autoantibodies in rheumatoid arthritisClinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis.Rituximab treatment of the anti-synthetase syndrome: a retrospective case series.Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis.
P2860
Q27014908-3E5CA290-1FB4-408B-AB78-CC613C73167AQ30249874-D3158376-1E1D-4C71-88F1-C29381C75957Q33639777-7B34173C-D6B0-4961-98D9-A269264B58E0Q33737250-19EC3CE7-3D8E-483C-9785-05076ABE9ADDQ33907242-4CB46D43-A4D1-4286-A702-C404DAE8E337Q34349952-0C026A27-7358-4AC9-8C59-72FF91F3756DQ34443730-64CCF9FE-F909-4349-B037-9AC055EA54D5Q34635470-C086CC91-3879-4582-9C98-621F44369990Q34644756-E2BA1F98-FB39-4B60-A059-AEBAB9AF86AAQ35421571-6FA971E3-9487-4141-9431-5683610BACEAQ35761863-0D60B8D1-9917-470E-BCFB-A2142B20FADBQ36015534-74DFDF06-D0AA-441B-A233-FC139DE9E9B4Q36050378-E51D51BC-DB71-44C8-83BB-0C5F8FB6B3CBQ36913833-A24FDAC8-AAB2-44FB-A55E-F4B35FFC71EEQ37092487-F4D25D00-B857-490F-A0AF-1EDAB4C05182Q37261129-B2494B82-69A7-41C1-A00B-451473E1637EQ37587375-A3B174F2-7255-4EE6-9982-9B2BDFB293F9Q37734933-9FE635C7-5285-4B20-84AC-ED9274AC31DEQ37830968-59B56269-348F-4D75-9C63-DAD6A2927F6CQ37845609-506C111D-9CFF-4E38-9AC3-00F65DE9AD9EQ37937430-06885348-C06A-48DA-A637-106A2113B8C4Q37988393-733919B6-46B2-48C1-AE8D-A0E22482DFD1Q37990559-665EFED3-1D1C-407E-B184-67123A97164AQ38116464-B2E0B138-2C22-475F-A6CC-D5831CC94A14Q38124282-3F0BBA6B-EF35-4C9F-B5CE-94BA438E295EQ38450473-355FF3E7-8932-459C-A3D1-E282399CF9AAQ38613068-80779EF3-BF00-4A23-AD54-7A85DCE7F312Q38619523-5FDC60B3-2E22-4B56-AAF8-92D0F0622FEEQ41019090-80E93021-5A1A-42BF-B2EC-966848AC6923Q41532897-BEFB0D02-97E7-4ADC-973E-2CF501AADB8EQ41605320-E5B7F410-6DD4-4100-BAC3-919AFBFCFD4EQ41674222-879CFBB9-557A-47B5-8E69-66DBB6EB6BF4Q42181812-0DB86CA3-7C32-483E-BB0A-8E26B95F2D73Q42592977-BAB7C4FB-F4BC-4F11-8517-9FD895C2CA3DQ43055408-9047A271-7CAD-4FCB-A665-022F5E037D66Q45076328-6CECF9E1-9B1E-46E3-996B-1C34346413DDQ47372819-8C5B319B-6E44-4BBF-97C8-F91E619CBC10Q50086896-F28C88BC-59A2-4F25-AE92-F700FEFAB0FEQ54635163-10A2152C-D6B8-468A-BDEF-14C52ED8DE1A
P2860
Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Interstitial lung disease in p ...... monary function and radiology.
@en
type
label
Interstitial lung disease in p ...... monary function and radiology.
@en
prefLabel
Interstitial lung disease in p ...... monary function and radiology.
@en
P2093
P2860
P356
P1476
Interstitial lung disease in p ...... monary function and radiology.
@en
P2093
Göran Tornling
Jenny Vikgren
Lennart Jorfeldt
Marianne Boijsen
Maryam Fathi
P2860
P304
P356
10.1002/ART.23571
P577
2008-05-01T00:00:00Z